Regeneration and bioengineering of the kidney: Current status and future challenges

Current Urology Reports

Volumn 15, Issue 1, 2014, Pages

  Salvatori, Marcus ^a   Peloso, Andrea ^b   Katari, Ravi ^b   Orlando, Giuseppe ^b  

^a OXFORD UNIVERSITY HOSPITALS NHS FOUNDATION TRUST   (United Kingdom)

^b WAKE FOREST SCHOOL OF MEDICINE   (United States)

Author keywords

ARFAcuteRenalFailure; BAKBio ArtificialKidney; BMDCBone Marrow Derived Stem Cell; CKDChronic Kidney Disease; DRTDecellularization Recellularization Technology; ECMExtracellularMatrix; ESC Embryonic Stem Cell; ESRD End Stage RenalDisease; HafscHuman Amniotic Fluid Derived Stem Cells; IPSC Induced Pluripotent Stem Cells; MSC Mesenchymal Stem Cell; RADRenalTubuleAssisted Device; RMRegenerativeMedicine

Indexed keywords

GROWTH FACTOR;

AMNIOTIC FLUID CELL; ARTICLE; BIOARTIFICIAL ORGAN; BIOENGINEERING; CELL DIFFERENTIATION; CELL THERAPY; DEVELOPMENTAL BIOLOGY; EMBRYONIC STEM CELL; END STAGE RENAL DISEASE; EXTRACELLULAR MATRIX; HEMATOPOIETIC STEM CELL; HUMAN; KIDNEY; KIDNEY ALLOGRAFT; KIDNEY FUNCTION; KIDNEY PARENCHYMA; KIDNEY TRANSPLANTATION; NEPHRON; NONHUMAN; PARACRINE SIGNALING; PLURIPOTENT STEM CELL; TISSUE REGENERATION; TISSUE REPAIR; CHRONIC KIDNEY FAILURE; PHYSIOLOGY; REGENERATION; REGENERATIVE MEDICINE; REVIEW; STEM CELL; TISSUE ENGINEERING;

BIOARTIFICIAL ORGANS; HUMANS; KIDNEY; KIDNEY FAILURE, CHRONIC; REGENERATION; REGENERATIVE MEDICINE; RENAL INSUFFICIENCY, CHRONIC; STEM CELLS; TISSUE ENGINEERING;

EID: 84890926411     PISSN: 15272737     EISSN: 15346285     Source Type: Journal    
DOI: 10.1007/s11934-013-0379-9     Document Type: Article

References (124)

1. Peralta CA et al. Control of hypertension in adults with chronic kidney disease in the United States. Hypertension. 2005;45(6): 1119-24.
2. Sarafidis PA et al. Hypertension awareness, treatment, and control in chronic kidney disease. Am J Med. 2008;121(4): 332-40.
3. Tonelli M et al. Chronic kidney disease and mortality risk: a systematic review. J Am Soc Nephrol. 2006;17(7): 2034-47.
4. Guild WR et al. Successful homotransplantation of the kidney in an identical twin. Trans Am Clin Climatol Assoc. 1955;67: 167-73.
5. Jassal SV et al. Kidney transplantation in the elderly: a decision analysis. J Am Soc Nephrol. 2003;14(1): 187-96.
6. Laupacis A et al. A study of the quality of life and cost-utility of renal transplantation. Kidney Int. 1996;50(1): 235-42.
7. Oliver J. Correlations of structure and function and mechanisms of recovery in acute tubular necrosis. Am J Med. 1953;15(4): 535-57.
8. Cuppage FE, Tate A. Repair of the nephron following injury with mercuric chloride. Am J Pathol. 1967;51(3): 405-29.
9. Haagsma BH, Pound AW. Mercuric chloride-induced tubulonecrosis in the rat kidney: the recovery phase. Br J Exp Pathol. 1980;61(3): 229-41.
10. Nony P, Boissel JP. Use of sensitivity functions to characterise and compare the forgiveness of drugs. Clin Pharmacokinet. 2002;41(5): 371-80.
11. Pawar S, Kartha S, Toback FG. Differential gene expression in migrating renal epithelial cells after wounding. J Cell Physiol. 1995;165(3): 556-65.
12. Counts RS et al. Nephrotoxicant inhibition of renal proximal tubule cell regeneration. Am J Physiol. 1995;269(2 Pt 2):F274-81.
13. Kawaida K et al. Hepatocyte growth factor prevents acute renal failure and accelerates renal regeneration in mice. Proc Natl Acad Sci U S A. 1994;91(10): 4357-61.
14. Ichimura T et al. FGF-1 in normal and regenerating kidney: expression in mononuclear, interstitial, and regenerating epithelial cells. Am J Physiol. 1995;269(5 Pt 2):F653-62.
15. Haq M et al. Role of IL-1 in renal ischemic reperfusion injury. J Am Soc Nephrol. 1998;9(4): 614-9.
16. Nowak G, Schnellmann RG. Renal cell regeneration following oxidant exposure: inhibition by TGF-beta1 and stimulation by ascorbic acid. Toxicol Appl Pharmacol. 1997;145(1): 175-83.
17. Grobstein C. Morphogenetic interaction between embryonic mouse tissues separated by a membrane filter. Nature. 1953;172(4384): 869-70.
18. Grobstein C. Inductive epitheliomesenchymal interaction in cultured organ rudiments of the mouse. Science. 1953;118(3054): 52-5.
19. Grobstein C. Trans-filter induction of tubules in mouse metanephrogenic mesenchyme. Exp Cell Res. 1956;10(2): 424-40.
20. Grobstein C. Inductive tissue interaction in development. Adv Cancer Res. 1956;4: 187-236.
21. Kitamura S et al. Establishment and characterization of renal progenitor like cells from S3 segment of nephron in rat adult kidney. FASEB J. 2005;19(13): 1789-97.
22. Lindgren D et al. Isolation and characterization of progenitor-like cells from human renal proximal tubules. Am J Pathol. 2011;178(2): 828-37.
23. Maeshima A, Yamashita S, Nojima Y. Identification of renal progenitor-like tubular cells that participate in the regeneration processes of the kidney. J Am Soc Nephrol. 2003;14(12): 3138-46.
24. Sagrinati C et al. Isolation and characterization of multipotent progenitor cells from the Bowman's capsule of adult human kidneys. J Am Soc Nephrol. 2006;17(9): 2443-56.
25. Oliver JA et al. The renal papilla is a niche for adult kidney stem cells. J Clin Invest. 2004;114(6): 795-804.
26. Kobayashi A, Valerius MT, Mugford JW, et al. Pax2 maintains a selfrenewing nephron progenitor population by repressing interstitial cell fates during mammalian kidney development. San Diego: 2009 American Society of Nephrology Meeting; 2009.
27. Kobayashi A et al. Six2 defines and regulates a multipotent selfrenewing nephron progenitor population throughout mammalian kidney development. Cell Stem Cell. 2008;3(2): 169-81.
28. SelfMet al. Six2 is required for suppression of nephrogenesis and progenitor renewal in the developing kidney. EMBO J. 2006;25(21): 5214-28.
29. Bussolati B et al. Isolation of renal progenitor cells from adult human kidney. Am J Pathol. 2005;166(2): 545-55.
30. Ronconi E et al. Regeneration of glomerular podocytes by human renal progenitors. J Am Soc Nephrol. 2009;20(2): 322-32.
31. Martin GR. Isolation of a pluripotent cell line from early mouse embryos cultured inmediumconditioned by teratocarcinoma stem cells. Proc Natl Acad Sci U S A. 1981;78(12): 7634-8. First, groundbreaking report on the isolation of embryonic stem cells in mice. This paper came out almost at the same time as another paper from Evans and Kaufman..
32. Mae S et al. Combination of small molecules enhances differentiation ofmouse embryonic stemcells into intermediatemesoderm through BMP7-positive cells. Biochem Biophys Res Commun. 2010;393(4): 877-82.
33. Schuldiner M et al. Effects of eight growth factors on the differentiation of cells derived from human embryonic stem cells. Proc Natl Acad Sci U S A. 2000;97(21): 11307-12.
34. Kim D, Dressler GR. Nephrogenic factors promote differentiation of mouse embryonic stem cells into renal epithelia. J Am Soc Nephrol. 2005;16(12): 3527-34.
35. Vigneau C et al. Mouse embryonic stem cell-derived embryoid bodies generate progenitors that integrate long term into renal proximal tubules in vivo. J Am Soc Nephrol. 2007;18(6): 1709-20.
36. Kobayashi Tet al.Wnt4-transformed mouse embryonic stem cells differentiate into renal tubular cells. Biochem Biophys Res Commun. 2005;336(2): 585-95.
37. Reubinoff BE et al. Embryonic stem cell lines from human blastocysts: somatic differentiation in vitro. Nat Biotechnol. 2000;18(4): 399-404.
38. Steenhard BM et al. Integration of embryonic stem cells in metanephric kidney organ culture. J Am Soc Nephrol. 2005;16(6): 1623-31.
39. Fang TC et al. Exogenous bone marrow cells do not rescue nonirradiated mice from acute renal tubular damage caused by HgCl2, despite establishment of chimaerism and cell proliferation in bone marrow and spleen. Cell Prolif. 2008;41(4): 592-606.
40. Poulsom R et al. Bone marrow contributes to renal parenchymal turnover and regeneration. J Pathol. 2001;195(2): 229-35.
41. Hayakawa M et al. Role of bone marrow cells in the healing process of mouse experimental glomerulonephritis. Pediatr Res. 2005;58(2): 323-8.
42. Burdon TJ et al. Bone marrow stem cell derived paracrine factors for regenerative medicine: current perspectives and therapeutic potential. Bone Marrow Res. 2011;2011:207326.
43. Camussi G, Deregibus MC, Tetta C. Paracrine/endocrine mechanism of stem cells on kidney repair: role of microvesicle-mediated transfer of genetic information. Curr Opin Nephrol Hypertens. 2010;19(1): 7-12.
44. He J et al. Bone marrow stem cells-derived microvesicles protect against renal injury in the mouse remnant kidney model. Nephrology (Carlton). 2012;17(5): 493-500.
45. Ikarashi K et al. Bone marrow cells contribute to regeneration of damaged glomerular endothelial cells. Kidney Int. 2005;67(5): 1925-33.
46. Ito Tet al. Bone marrow is a reservoir of repopulatingmesangial cells during glomerular remodeling. J Am Soc Nephrol. 2001;12(12): 2625-35.
47. Li J et al. The contribution of bone marrow-derived cells to the development of renal interstitial fibrosis. Stem Cells. 2007;25(3): 697-706.
48. Lindoso RS et al. Paracrine interaction between bone marrowderived stem cells and renal epithelial cells. Cell Physiol Biochem. 2011;28(2): 267-78.
49. Masuya M et al. Hematopoietic origin of glomerular mesangial cells. Blood. 2003;101(6): 2215-8.
50. McTaggart SJ,AtkinsonK.Mesenchymal stem cells: immunobiology and therapeutic potential in kidney disease. Nephrology (Carlton). 2007;12(1): 44-52.
51. Perry J et al. Type IV collagen induces podocytic features in bone marrow stromal stem cells in vitro. J Am Soc Nephrol. 2006;17(1): 66-76.
52. Prodromidi EI et al. Bone marrow-derived cells contribute to podocyte regeneration and amelioration of renal disease in a mouse model of Alport syndrome. Stem Cells. 2006;24(11): 2448-55.
53. Qian H et al. Bone marrow mesenchymal stem cells ameliorate rat acute renal failure by differentiation into renal tubular epitheliallike cells. Int J Mol Med. 2008;22(3): 325-32.
54. Reis LA et al. Bone marrow-derived mesenchymal stem cells repaired but did not prevent gentamicin-induced acute kidney injury through paracrine effects in rats. PLoS One. 2012;7(9): e44092.
55. Rookmaaker MB et al. Bone-marrow-derived cells contribute to glomerular endothelial repair in experimental glomerulonephritis. Am J Pathol. 2003;163(2): 553-62.
56. Sugimoto H et al. Bone-marrow-derived stem cells repair basement membrane collagen defects and reverse genetic kidney disease. Proc Natl Acad Sci U S A. 2006;103(19): 7321-6.
57. Suzuki A et al. Platelet-derived growth factor plays a critical role to convert bone marrow cells into glomerular mesangial-like cells. Kidney Int. 2004;65(1): 15-24.
58. Togel F et al. VEGF is a mediator of the renoprotective effects of multipotent marrow stromal cells in acute kidney injury. J Cell Mol Med. 2009;13(8B): 2109-14.
59. Yadav N et al. Bone marrow cells contribute to tubular epithelium regeneration following acute kidney injury induced by mercuric chloride. Indian J Med Res. 2012;136(2): 211-20.
60. Perin L et al. Renal differentiation of amniotic fluid stem cells. Cell Prolif. 2007;40(6): 936-48.
61. Rota C et al. Human amniotic fluid stem cell preconditioning improves their regenerative potential. Stem Cells Dev. 2012;21(11): 1911-23.
62. Siegel N et al. Contribution of human amniotic fluid stem cells to renal tissue formation depends on mTOR. Hum Mol Genet. 2010;19(17): 3320-31.
63. Hauser PV et al. Stem cells derived from human amniotic fluid contribute to acute kidney injury recovery. Am J Pathol. 2010;177(4): 2011-21.
64. Polo JM et al. Cell type of origin influences the molecular and functional properties of mouse induced pluripotent stem cells. Nat Biotechnol. 2010;28(8): 848-55.
65. Song B et al.Generation of induced pluripotent stem cells from human kidney mesangial cells. J Am Soc Nephrol. 2011;22(7): 1213-20.
66. Takahashi K, Yamanaka S. Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell. 2006;126(4): 663-76.
67. Zhao T et al. Immunogenicity of induced pluripotent stem cells. Nature. 2011;474(7350): 212-5.
68. Zhou T et al. Generation of induced pluripotent stem cells from urine. J Am Soc Nephrol. 2011;22(7): 1221-8.
69. Bratt-Leal AM, Carpenedo RL, McDevitt TC. Engineering the embryoid body microenvironment to direct embryonic stem cell differentiation. Biotechnol Prog. 2009;25(1): 43-51.
70. Blum B et al. The anti-apoptotic gene survivin contributes to teratoma formation by human embryonic stem cells. Nat Biotechnol. 2009;27(3): 281-7.
71. Phinney DG, Prockop DJ. Concise review: mesenchymal stem/ multipotent stromal cells: the state of transdifferentiation and modes of tissue repair-current views. Stem Cells. 2007;25(11): 2896-902.
72. Thirabanjasak D, Tantiwongse K, Thorner PS. Angiomyeloproliferative lesions following autologous stem cell therapy. J Am Soc Nephrol. 2010;21(7): 1218-22.
73. Woolf AS et al. Creation of a functioning chimeric mammalian kidney. Kidney Int. 1990;38(5): 991-7.
74. Rogers SA et al. Transplantation of developing metanephroi into adult rats. Kidney Int. 1998;54(1): 27-37.
75. Statter MB et al. Correlation of fetal kidney and testis congenic graft survival with reduced major histocompatibility complex burden. Transplantation. 1989;47(4): 651-60.
76. Abrahamson DR et al. Glomerular development in intraocular and intrarenal grafts of fetal kidneys. Lab Invest. 1991;64(5): 629-39.
77. Samstein B, Platt JL. Physiologic and immunologic hurdles to xenotransplantation. J Am Soc Nephrol. 2001;12(1): 182-93.
78. Dai Yet al. Targeted disruption of the alpha1,3-galactosyltransferase gene in cloned pigs. Nat Biotechnol. 2002;20(3): 251-5.
79. Cascalho M, Platt JL. Xenotransplantation and other means of organ replacement. Nat Rev Immunol. 2001;1(2): 154-60.
80. Rogers SA, Talcott M, Hammerman MR. Transplantation of pig metanephroi. ASAIO J. 2003;49(1): 48-52.
81. Dekel B et al. Engraftment and differentiation of human metanephroi into functional mature nephrons after transplantation into mice is accompanied by a profile of gene expression similar to normal human kidney development. J Am Soc Nephrol. 2002;13(4): 977-90.
82. Hammerman MR. Renal organogenesis from transplanted metanephric primordia. J Am Soc Nephrol. 2004;15(5): 1126-32.
83. Steer DL et al. A strategy for in vitro propagation of rat nephrons. Kidney Int. 2002;62(6): 1958-65.
84. Rosines E et al. Constructing kidney-like tissues from cells based on programs for organ development: toward a method of in vitro tissue engineering of the kidney. Tissue Eng Part A. 2010;16(8): 2441-55.
85. Xinaris C et al. In vivo maturation of functional renal organoids formed from embryonic cell suspensions. J Am Soc Nephrol. 2012;23(11): 1857-68.
86. Tasnim F et al. Achievements and challenges in bioartificial kidney development. Fibrogenesis Tissue Repair. 2010;3:14.
87. Aebischer P et al. The bioartificial kidney: progress towards an ultrafiltration device with renal epithelial cells processing. Life Support Syst. 1987;5(2): 159-68.
88. Humes HD et al. Initial clinical results of the bioartificial kidney containing human cells in ICU patients with acute renal failure. Kidney Int. 2004;66(4): 1578-88.
89. Tumlin J et al. Efficacy and safety of renal tubule cell therapy for acute renal failure. J Am Soc Nephrol. 2008;19(5): 1034-40.
90. Bissell MJ, Hall HG, Parry G. How does the extracellular matrix direct gene expression? J Theor Biol. 1982;99(1): 31-68.
91. Lelongt B, Ronco P. Role of extracellular matrix in kidney development and repair. Pediatr Nephrol. 2003;18(8): 731-42.
92. Muller U et al. Integrin alpha8beta1 is critically important for epithelial-mesenchymal interactions during kidney morphogenesis. Cell. 1997;88(5): 603-13.
93. Mason RM, Wahab NA. Extracellular matrix metabolism in diabetic nephropathy. J Am Soc Nephrol. 2003;14(5): 1358-73.
94. Song JJ, Ott HC. Organ engineering based on decellularized matrix scaffolds. Trends Mol Med. 2011;17(8): 424-32.
95. Orlando G et al. Regenerative medicine as applied to solid organ transplantation: current status and future challenges. Transpl Int. 2011;24(3): 223-32.
96. Orlando G et al. Regenerative medicine and organ transplantation: past, present, and future. Transplantation. 2011;91(12): 1310-7.
97. Orlando G et al. Regenerative medicine as applied to general surgery. Ann Surg. 2012;255(5): 867-80.
98. Badylak SF et al. Engineered whole organs and complex tissues. Lancet. 2012;379(9819): 943-52. Seminal review on the cellscaffold technology which seems to offer the most promising approach to renal bioengineering, while granting the quickest route to clinical application..
99. Orlando G et al. Production and implantation of renal extracellular matrix scaffolds from porcine kidneys as a platform for renal bioengineering investigations. Ann Surg. 2012;256(2): 363-70. Seminal study providing evidence that porcine kidneys can be decellularized to produce acellular scaffolds. Such scaffolds represent an ideal platform for renal bioengineering investigations. .
100. Wang Y et al. Lineage restriction of human hepatic stem cells to mature fates is made efficient by tissue-specific biomatrix scaffolds. Hepatology. 2011;53(1): 293-305.
101. Ross EA et al. Embryonic stem cells proliferate and differentiate when seeded into kidney scaffolds. J Am Soc Nephrol. 2009;20(11): 2338-47.
102. Ng SL et al. Lineage restricted progenitors for the repopulation of decellularized heart. Biomaterials. 2011;32(30): 7571-80.
103. Hynes RO. The extracellular matrix: not just pretty fibrils. Science. 2009;326(5957): 1216-9.
104. Badylak SF, Taylor D, Uygun K.Whole-organ tissue engineering: decellularization and recellularization of three-dimensional matrix scaffolds. Annu Rev Biomed Eng. 2011;13: 27-53.
105. Gilbert TW, Sellaro TL, Badylak SF. Decellularization of tissues and organs. Biomaterials. 2006;27(19): 3675-83.
106. Crapo PM et al. Biologic scaffolds composed of central nervous system extracellular matrix. Biomaterials. 2012;33(13): 3539-47.
107. Badylak SF, Gilbert TW. Immune response to biologic scaffold materials. Semin Immunol. 2008;20(2): 109-16.
108. Brown BN et al. Macrophage phenotype and remodeling outcomes in response to biologic scaffolds with and without a cellular component. Biomaterials. 2009;30(8): 1482-91.
109. Reing JE et al. The effects of processing methods uponmechanical and biologic properties of porcine dermal extracellular matrix scaffolds. Biomaterials. 2010;31(33): 8626-33.
110. Brown B et al. The basement membrane component of biologic scaffolds derived from extracellular matrix. Tissue Eng. 2006;12(3): 519-26.
111. Baptista PM et al. The use of whole organ decellularization for the generation of a vascularized liver organoid. Hepatology. 2011;53(2): 604-17.
112. Song JJ et al. Enhanced in vivo function of bioartificial lungs in rats. Ann Thorac Surg. 2011;92(3): 998-1005. discussion 1005-6.
113. Martinello, T., et al., Successful recellularization of human tendon scaffolds using adipose-derived mesenchymal stem cells and collagen gel. J Tissue Eng Regen Med, 2012
114. Honge JL et al. Recellularization of aortic valves in pigs. Eur J Cardiothorac Surg. 2011;39(6): 829-34.
115. Loai Y et al. Bladder tissue engineering: tissue regeneration and neovascularization of HA-VEGF-incorporated bladder acellular constructs in mouse and porcine animal models. J Biomed Mater Res A. 2010;94(4): 1205-15.
116. Wicha MS et al. Extracellular matrix promotes mammary epithelial growth and differentiation in vitro. Proc Natl Acad Sci U S A. 1982;79(10): 3213-7.
117. Liu CX et al. Preparation of whole-kidney acellular matrix in rats by perfusion. Nan Fang Yi Ke Da Xue Xue Bao. 2009;29(5): 979-82.
118. Nakayama KH et al. Decellularized rhesus monkey kidney as a three-dimensional scaffold for renal tissue engineering. Tissue Eng Part A. 2010;16(7): 2207-16.
119. Sullivan DC et al. Decellularization methods of porcine kidneys for whole organ engineering using a high-throughput system. Biomaterials. 2012;33(31): 7756-64.
120. Narlis M et al. Pax2 and pax8 regulate branching morphogenesis and nephron differentiation in the developing kidney. J Am Soc Nephrol. 2007;18(4): 1121-9.
121. Shao X et al. A minimal Ksp-cadherin promoter linked to a green fluorescent protein reporter gene exhibits tissue-specific expression in the developing kidney and genitourinary tract. J Am Soc Nephrol. 2002;13(7): 1824-36.
122. Gupta S et al. Isolation and characterization of kidney-derived stem cells. J Am Soc Nephrol. 2006;17(11): 3028-40.
123. Bagetti Filho HJ et al. Pig kidney: anatomical relationships between the renal venous arrangement and the kidney collecting system. J Urol. 2008;179(4): 1627-30.
124. Al-Awqati Q, Oliver JA. Stem cells in the kidney. Kidney Int. 2002;61(2): 387-95.